Jorge J. Llibre-Guerra

2 months ago | nature.com | Jorge J. Llibre-Guerra |Nelly Joseph-Mathurin |Kathleen Carter |Eric McDade |Brian Gordon |Alan E. Renton | +8 more

AbstractWe conducted an in-depth longitudinal study on an individual carrying the presenilin 2 p.Asn141Ile mutation, traditionally associated with dominantly inherited Alzheimer’s disease (AD), who has remarkably remained asymptomatic past the expected age of clinical onset. This study combines genetic, neuroimaging and biomarker analyses to explore the underpinnings of this resilience.

Nov 17, 2024 | nature.com | Stephan A. Kaeser |Christian la Fougère |Jonathan Voglein |Johannes Levin |Nick Fox |Henrik Zetterberg | +16 more

AbstractDisease-modifying therapies for Alzheimer’s disease (AD) are likely to be most beneficial when initiated in the presymptomatic phase. To track the benefit of such interventions, fluid biomarkers are of great importance, with neurofilament light chain protein (NfL) showing promise for monitoring neurodegeneration and predicting cognitive outcomes.

Nov 17, 2024 | nature.com | Stephan A. Kaeser |Christian la Fougère |Jonathan Voglein |Johannes Levin |Nick Fox |Henrik Zetterberg | +16 more

AbstractDisease-modifying therapies for Alzheimer’s disease (AD) are likely to be most beneficial when initiated in the presymptomatic phase. To track the benefit of such interventions, fluid biomarkers are of great importance, with neurofilament light chain protein (NfL) showing promise for monitoring neurodegeneration and predicting cognitive outcomes.

Jan 20, 2024 | thelancet.com | Yoav Ben-Shlomo |Sirwan K Darweesh |Movement Disorders |Jorge J. Llibre-Guerra

1. The uses of ‘uses of epidemiology’. Int J Epidemiol. 2001; 30: 1146-11552. Pringsheim T Jette N Frolkis A Steeves TD The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014; 29: 1583-15903. Dorsey ER Constantinescu R Thompson JP et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007; 68: 384-3864. Berg D Postuma RB Bloem B et al. Time to redefine PD?